The first post-authorization safety analysis of Pfizerâs Abrysvo RSV vaccine found the average time between vaccination and preterm birth was three days. Two-thirds of reported…
Posts tagged as “RSV vaccine”
By Brenda Baletti, Ph.D. Pfizer plans to use data from a clinical trial it concluded last month to ask regulators to expand approval of its…
The Centers for Disease Control and Prevention warned of a shortage of a drug designed to protect newborns from severe cases of respiratory syncytial virus…
According to the Centers for Disease Control and Prevention, vaccine hesitancy among pregnant women is on the rise, causing concern among some doctors and public…